CONCERT PHARMACEUTICALS, INC. Contracts & Agreements
50 Contracts & Agreements
- Business Finance (20 contracts)
- Business Operations (2)
- Human Resources (17)
- Intellectual Property (2)
- Mergers & Acquisitions (1)
- Real Estate (2)
- Uncategorized (6)
- Contingent Value Rights Agreement, dated as of March 6, 2023, by and among Sun Pharmaceutical Holdings USA, Inc., Sun Pharmaceutical Industries Ltd., Computershare Inc. and... (Filed With SEC on March 6, 2023)
- Agreement and Plan of Merger, dated as of January 19, 2023, by and among Sun Pharmaceutical Industries Ltd., Foliage Merger Sub, Inc. and Concert Pharmaceuticals, Inc (Filed With SEC on January 19, 2023)
- Underwriting Agreement, dated June 1, 2022, by and between the Company and Jefferies LLC and Truist Securities, Inc., as representatives of the several underwriters named therein (Filed With SEC on June 3, 2022)
- Form of Warrant Amendment Agreement (Filed With SEC on June 3, 2022)
- Description of Capital Stock (Filed With SEC on March 3, 2022)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on March 3, 2022)
- Royalty Purchase Agreement, dated as of November 3, 2021, by and among the Registrant and the Buyers (Filed With SEC on March 3, 2022)
- Form of Warrant (Filed With SEC on November 8, 2021)
- Securities Purchase Agreement, dated November 3, 2021 (Filed With SEC on November 8, 2021)
- Amendment to Asset Purchase Agreement, dated as of May 17, 2021, by and among the Registrant, Vertex Pharmaceuticals (Europe) Limited, as Buyer, and Vertex Pharmaceuticals... (Filed With SEC on May 17, 2021)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on February 25, 2021)
- Description of Capital Stock (Filed With SEC on February 27, 2020)
- Employment Agreement, dated as of October 31, 2018, by and between the Registrant and Roger D. Tung (Filed With SEC on February 27, 2020)
- Form of Employment Agreement by and between the Registrant and each non-CEO executive officer (Filed With SEC on February 27, 2020)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on February 27, 2020)
- Underwriting Agreement, dated as of January 28, 2020, by and between the Company and Jefferies LLC, as representative of the several underwriters named therein (Filed With SEC on January 28, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on January 28, 2020)
- Open Market Sale Agreement dated March 1, 2019 by and between Concert Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on March 1, 2019)
- Summary of Director Compensation Program (Filed With SEC on February 28, 2019)
- Form of Employment Agreement by and between the Registrant and each of its executive officers (Filed With SEC on March 1, 2018)
- Lease Agreement, dated as of December 21, 2017, by and between the Registrant and HCP/King Hayden Campus LLC (Filed With SEC on March 1, 2018)
- Summary of Director Compensation Program (Filed With SEC on March 1, 2018)
- Concert Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement Granted Under 2014 Stock Incentive Plan (Filed With SEC on July 10, 2017)
- SUMMARY OF DIRECTOR COMPENSATION PROGRAM (Filed With SEC on March 1, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 11, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 11, 2015)
- CONCERT PHARMACEUTICALS, INC. 3,300,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 19, 2015)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 2, 2015)
- SUMMARY OF DIRECTOR COMPENSATION PROGRAM (Filed With SEC on March 2, 2015)
- AMENDMENT OF LEASE (Filed With SEC on August 12, 2014)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 12, 2014)
- CONCERT PHARMACEUTICALS, INC. [] Shares Common Stock ($0.001 par value per share) UNDERWRITING AGREEMENT [Pricing date] UNDERWRITING AGREEMENT (Filed With SEC on February 3, 2014)
- Signature(s)Guaranteed: Medallion Guarantee Stamp (Filed With SEC on February 3, 2014)
- CONCERT PHARMACEUTICALS, INC. 2014 STOCK INCENTIVE PLAN January 29, 2014 (Filed With SEC on February 3, 2014)
- CONCERT PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2014 STOCK INCENTIVE PLAN (Filed With SEC on February 3, 2014)
- CONCERT PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENT GRANTEDUNDER 2014 STOCK INCENTIVE PLAN (Filed With SEC on February 3, 2014)
- DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on February 3, 2014)
- DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on February 3, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on February 3, 2014)
- THIRD AMENDED AND RESTATED REGISTRATION RIGHTSAGREEMENT (Filed With SEC on January 13, 2014)
- WARRANT AGREEMENT To Purchase Shares of the Series C Preferred Stock of CONCERT PHARMACEUTICALS, INC. Dated as of December 22, 2011 (the Effective Date) (Filed With SEC on January 13, 2014)
- CONCERT PHARMACEUTICALS, INC. AMENDED AND RESTATED 2006 STOCK OPTION AND GRANT PLAN (Filed With SEC on January 13, 2014)
- CONCERT PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under Amended and Restated 2006 Stock Option and Grant Plan (Filed With SEC on January 13, 2014)
- CONCERT PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under Amended and Restated 2006 Stock Option and Grant Plan (Filed With SEC on January 13, 2014)
- 99 Hayden Avenue Suite 500 Lexington, MA 02421 ###-###-#### (Tel) 781 ###-###-#### (Fax) - 1 - (Filed With SEC on January 13, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on January 13, 2014)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on January 13, 2014)
- CONCERT PHARMACEUTICALS, INC. LEDGEMONT DEVELOPMENT CENTER LEXINGTON, MA (Filed With SEC on January 13, 2014)
- SUMMARY OF EXECUTIVE BONUS PROGRAM (Filed With SEC on January 13, 2014)
- SUMMARY OF DIRECTOR COMPENSATION PROGRAM (Filed With SEC on January 13, 2014)